Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Tenofovir Alafenamide (25mg) Tablet
Therapeutic Category
Gynecology and Fertility, Antiviral
Dosage Form
Tablet
Packaging Type
Bottle
Packaging
30 Tablets
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tenofit 25 Tablet (Tenofovir Alafenamide 25mg) is a once-daily antiretroviral tablet indicated for HIV treatment with improved renal and bone safety profile. Tenofovir Alafenamide inhibits viral reverse transcriptase, effectively reducing viral replication and enhancing immune function.
It is widely prescribed by infectious disease specialists, HIV clinics, and hospitals, ensuring strong institutional demand. Tenofit 25 Tablet offers a profitable PCD pharma franchise opportunity, ideal for B2B distribution, manufacturing, and export, catering to the growing antiretroviral therapy segment with high patient compliance.
Generally well-tolerated. Rarely, may cause mild nasal irritation, sneezing, or a temporary burning sensation.
Nasal dryness and irritation Nasal congestion due to colds, flu, or allergies Daily nasal hygiene Safe for infants, children, and adults Can be used along with medicated nasal sprays for better effect
For nasal use only. Ensure the nozzle does not touch any surface to prevent contamination. Safe for frequent and long-term use. Consult a doctor if symptoms persist or worsen.
Store at room temperature below 25°C. Do not freeze. Keep out of reach of children. Use within the recommended time after opening.
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Propionate (0.005% w/v)
Composition : Mometasone (50mcg)
Composition : Xylometazoline (0.1% w/v)
Composition : Xylometazoline (0.05% w/v)
Composition : Sodium Chloride I.P. 0.65% w/v + Benzalkonium Chloride Solution I.P. 0.02% w/v Nasal Drop
Composition : Mometasone Furoate (50mcg) + Azelastine Hydrochloride (140mcg) Nasal Spray
Composition : Calcitonin 200IU Nasal spray
Composition : Oxymetazoline (0.025% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tenofovir Alafenamide 25mg Tablet has growing demand in the antiviral, hepatology, infectious disease, and specialty pharmaceutical segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty and chronic disease portfolios.
Medical distributors and agencies can benefit from demand for chronic viral infection management under specialist medical supervision. Tenofovir Alafenamide 25mg is an antiviral medication belonging to the nucleotide reverse transcriptase inhibitor (NRTI) class Commonly prescribed for the treatment of chronic Hepatitis B virus (HBV) infection in appropriate patients, as advised by healthcare professionals Helps suppress viral replication, supporting long-term management of chronic hepatitis B and reducing the risk of disease progression when taken as prescribed Provides targeted antiviral therapy with a dosage strength suitable for long-term treatment plans Oral tablet formulation offers convenient once-daily administration, promoting patient adherence Requires regular monitoring of liver function, kidney function, and overall treatment response during therapy Frequently utilized in hepatology clinics, gastroenterology departments, hospitals, and infectious disease centers Widely prescribed by hepatologists, gastroenterologists, infectious disease specialists, and general physicians managing chronic hepatitis B This strengthens a comprehensive antiviral and specialty healthcare portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tenofovir Alafenamide 25mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, long-term patient usage, specialty healthcare market opportunities, reliable supply chain support, and attractive margins in the antiviral segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.